Creative Medical Technology Holdings, Inc. Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
Creative Medical Technology Holdings, Inc. (CELZ) had Stock Repurchase Program Number Of Shares Authorized To Be Repurchased of 43.11 thousand shares as of 2016-02-02, per its 10-Q filed 2025-11-07.
Financial Statements › Notes › Equity
srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased · last filed 2025-11-07
- 2016-02-02: Stock Repurchase Program Number Of Shares Authorized To Be Repurchased 43.11K shares.
| Period end | Stock Repurchase Program Number Of Shares Authorized To Be Repurchased |
|---|---|
| 2016-02-02 | 43.11K shares 10-Q · filed 2025-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |